AAPL310.19-0.47 (-0.15%) ▼|ABBV254.72+0.07 (+0.03%) ▲|ABT95.76-0.08 (-0.08%) ▼|ACN139.72-2.42 (-1.70%) ▼|ADBE219.66-1.88 (-0.85%) ▼|AMAT561.93+7.43 (+1.34%) ▲|AMD503.05-13.07 (-2.53%) ▼|AMGN368.61+0.51 (+0.14%) ▲|AMT165.87+0.62 (+0.37%) ▲|AMZN240.88-5.10 (-2.07%) ▼|AVGO386.30+15.52 (+4.19%) ▲|AXP338.92-10.67 (-3.05%) ▼|BA223.74-7.95 (-3.43%) ▼|BAC58.56-1.30 (-2.17%) ▼|BKNG173.40-8.56 (-4.70%) ▼|BLK984.49-24.94 (-2.47%) ▼|BMY57.85-0.13 (-0.22%) ▼|BNY148.74-4.18 (-2.73%) ▼|BRK-B501.99-2.01 (-0.40%) ▼|C137.67-3.10 (-2.20%) ▼|CAT928.79-11.34 (-1.21%) ▼|CL93.54-1.49 (-1.57%) ▼|CMCSA23.64+0.23 (+0.96%) ▲|COF195.82-7.07 (-3.48%) ▼|COP111.02+2.58 (+2.38%) ▲|COST961.47+13.97 (+1.47%) ▲|CRM166.21-3.31 (-1.95%) ▼|CSCO112.84+1.05 (+0.94%) ▲|CVS104.82+0.49 (+0.47%) ▲|CVX177.91+3.90 (+2.24%) ▲|DE593.70-9.92 (-1.64%) ▼|DHR190.92-3.27 (-1.68%) ▼|DIS96.95-0.53 (-0.54%) ▼|DUK128.44+0.22 (+0.17%) ▲|EMR134.38-3.54 (-2.56%) ▼|FDX307.21-5.67 (-1.81%) ▼|GD372.79-1.85 (-0.49%) ▼|GE355.29-11.69 (-3.19%) ▼|GEV1,080.59+3.51 (+0.33%) ▲|GILD135.79-0.57 (-0.42%) ▼|GM75.61-0.42 (-0.55%) ▼|GOOG357.61-6.01 (-1.65%) ▼|GOOGL360.49-6.54 (-1.78%) ▼|GS1,015.78-27.20 (-2.61%) ▼|HD334.42-10.79 (-3.13%) ▼|HON220.51-4.54 (-2.02%) ▼|IBM301.06-5.08 (-1.66%) ▼|INTC105.18-5.21 (-4.72%) ▼|INTU271.62-9.56 (-3.40%) ▼|ISRG416.93-10.38 (-2.43%) ▼|JNJ267.07-0.17 (-0.06%) ▼|JPM332.48-6.75 (-1.99%) ▼|KO84.67+0.62 (+0.74%) ▲|LIN529.47-8.77 (-1.63%) ▼|LLY1,224.80-10.76 (-0.87%) ▼|LMT530.88-4.50 (-0.84%) ▼|LOW213.62-7.28 (-3.30%) ▼|LRCX328.26+2.13 (+0.65%) ▲|MA519.90-11.72 (-2.20%) ▼|MCD278.19-4.02 (-1.42%) ▼|MDLZ59.96-0.26 (-0.43%) ▼|MDT82.19-1.64 (-1.96%) ▼|META603.69-11.89 (-1.93%) ▼|MMM153.79-4.22 (-2.67%) ▼|MO73.76+0.80 (+1.10%) ▲|MRK126.64-2.22 (-1.72%) ▼|MS216.39-5.65 (-2.54%) ▼|MSFT382.58-6.26 (-1.61%) ▼|MU923.00-15.38 (-1.64%) ▼|NEE88.43-0.04 (-0.05%) ▼|NFLX75.92-0.27 (-0.35%) ▼|NKE42.38-0.83 (-1.92%) ▼|NOW106.69-4.04 (-3.65%) ▼|NVDA197.76+0.83 (+0.42%) ▲|ORCL137.98-3.63 (-2.56%) ▼|PEP144.40-0.58 (-0.40%) ▼|PFE24.29+0.22 (+0.91%) ▲|PG149.74-3.01 (-1.97%) ▼|PLTR128.87-5.50 (-4.09%) ▼|PM189.28+1.49 (+0.79%) ▲|QCOM182.46-0.51 (-0.28%) ▼|RTX197.03-3.82 (-1.90%) ▼|SBUX102.92-0.69 (-0.67%) ▼|SCHW102.19+0.26 (+0.26%) ▲|SO97.46+0.17 (+0.17%) ▲|SPG223.73-3.47 (-1.53%) ▼|T21.32+0.23 (+1.07%) ▲|TMO509.84-6.79 (-1.31%) ▼|TMUS183.43-1.30 (-0.70%) ▼|TSLA393.55-9.35 (-2.32%) ▼|TXN300.62+7.32 (+2.49%) ▲|UBER72.69-1.64 (-2.21%) ▼|UNH427.95-0.24 (-0.06%) ▼|UNP281.42-1.71 (-0.60%) ▼|UPS109.46-2.50 (-2.23%) ▼|USB61.05-1.84 (-2.93%) ▼|V348.13-4.08 (-1.16%) ▼|VZ43.02+0.43 (+1.01%) ▲|WFC85.47-1.71 (-1.96%) ▼|WMT113.43+1.89 (+1.69%) ▲|XOM142.63+0.94 (+0.66%) ▲|AAPL310.19-0.47 (-0.15%) ▼|ABBV254.72+0.07 (+0.03%) ▲|ABT95.76-0.08 (-0.08%) ▼|ACN139.72-2.42 (-1.70%) ▼|ADBE219.66-1.88 (-0.85%) ▼|AMAT561.93+7.43 (+1.34%) ▲|AMD503.05-13.07 (-2.53%) ▼|AMGN368.61+0.51 (+0.14%) ▲|AMT165.87+0.62 (+0.37%) ▲|AMZN240.88-5.10 (-2.07%) ▼|AVGO386.30+15.52 (+4.19%) ▲|AXP338.92-10.67 (-3.05%) ▼|BA223.74-7.95 (-3.43%) ▼|BAC58.56-1.30 (-2.17%) ▼|BKNG173.40-8.56 (-4.70%) ▼|BLK984.49-24.94 (-2.47%) ▼|BMY57.85-0.13 (-0.22%) ▼|BNY148.74-4.18 (-2.73%) ▼|BRK-B501.99-2.01 (-0.40%) ▼|C137.67-3.10 (-2.20%) ▼|CAT928.79-11.34 (-1.21%) ▼|CL93.54-1.49 (-1.57%) ▼|CMCSA23.64+0.23 (+0.96%) ▲|COF195.82-7.07 (-3.48%) ▼|COP111.02+2.58 (+2.38%) ▲|COST961.47+13.97 (+1.47%) ▲|CRM166.21-3.31 (-1.95%) ▼|CSCO112.84+1.05 (+0.94%) ▲|CVS104.82+0.49 (+0.47%) ▲|CVX177.91+3.90 (+2.24%) ▲|DE593.70-9.92 (-1.64%) ▼|DHR190.92-3.27 (-1.68%) ▼|DIS96.95-0.53 (-0.54%) ▼|DUK128.44+0.22 (+0.17%) ▲|EMR134.38-3.54 (-2.56%) ▼|FDX307.21-5.67 (-1.81%) ▼|GD372.79-1.85 (-0.49%) ▼|GE355.29-11.69 (-3.19%) ▼|GEV1,080.59+3.51 (+0.33%) ▲|GILD135.79-0.57 (-0.42%) ▼|GM75.61-0.42 (-0.55%) ▼|GOOG357.61-6.01 (-1.65%) ▼|GOOGL360.49-6.54 (-1.78%) ▼|GS1,015.78-27.20 (-2.61%) ▼|HD334.42-10.79 (-3.13%) ▼|HON220.51-4.54 (-2.02%) ▼|IBM301.06-5.08 (-1.66%) ▼|INTC105.18-5.21 (-4.72%) ▼|INTU271.62-9.56 (-3.40%) ▼|ISRG416.93-10.38 (-2.43%) ▼|JNJ267.07-0.17 (-0.06%) ▼|JPM332.48-6.75 (-1.99%) ▼|KO84.67+0.62 (+0.74%) ▲|LIN529.47-8.77 (-1.63%) ▼|LLY1,224.80-10.76 (-0.87%) ▼|LMT530.88-4.50 (-0.84%) ▼|LOW213.62-7.28 (-3.30%) ▼|LRCX328.26+2.13 (+0.65%) ▲|MA519.90-11.72 (-2.20%) ▼|MCD278.19-4.02 (-1.42%) ▼|MDLZ59.96-0.26 (-0.43%) ▼|MDT82.19-1.64 (-1.96%) ▼|META603.69-11.89 (-1.93%) ▼|MMM153.79-4.22 (-2.67%) ▼|MO73.76+0.80 (+1.10%) ▲|MRK126.64-2.22 (-1.72%) ▼|MS216.39-5.65 (-2.54%) ▼|MSFT382.58-6.26 (-1.61%) ▼|MU923.00-15.38 (-1.64%) ▼|NEE88.43-0.04 (-0.05%) ▼|NFLX75.92-0.27 (-0.35%) ▼|NKE42.38-0.83 (-1.92%) ▼|NOW106.69-4.04 (-3.65%) ▼|NVDA197.76+0.83 (+0.42%) ▲|ORCL137.98-3.63 (-2.56%) ▼|PEP144.40-0.58 (-0.40%) ▼|PFE24.29+0.22 (+0.91%) ▲|PG149.74-3.01 (-1.97%) ▼|PLTR128.87-5.50 (-4.09%) ▼|PM189.28+1.49 (+0.79%) ▲|QCOM182.46-0.51 (-0.28%) ▼|RTX197.03-3.82 (-1.90%) ▼|SBUX102.92-0.69 (-0.67%) ▼|SCHW102.19+0.26 (+0.26%) ▲|SO97.46+0.17 (+0.17%) ▲|SPG223.73-3.47 (-1.53%) ▼|T21.32+0.23 (+1.07%) ▲|TMO509.84-6.79 (-1.31%) ▼|TMUS183.43-1.30 (-0.70%) ▼|TSLA393.55-9.35 (-2.32%) ▼|TXN300.62+7.32 (+2.49%) ▲|UBER72.69-1.64 (-2.21%) ▼|UNH427.95-0.24 (-0.06%) ▼|UNP281.42-1.71 (-0.60%) ▼|UPS109.46-2.50 (-2.23%) ▼|USB61.05-1.84 (-2.93%) ▼|V348.13-4.08 (-1.16%) ▼|VZ43.02+0.43 (+1.01%) ▲|WFC85.47-1.71 (-1.96%) ▼|WMT113.43+1.89 (+1.69%) ▲|XOM142.63+0.94 (+0.66%) ▲|
25 C
New York
Wednesday, July 8, 2026

Tag: access

newssourceFORcompanyinformationcontent1releasesmarket

Neuro Balance Therapy Update: Strongest Non-Clinical Reflex Routine for Seniors Concerned About Instability

New 2025 At-Home Protocol Uses OTC Nerve Activation Tool to Reinforce Stability, Restore Confidence, and Help Reduce Fall Risk in Adults 60+ 
New 2025 At-Home Protocol Uses OTC Nerve Activation Tool to Reinforce Stability, Restore Confidence, and Help Reduce Fall Risk in Adults 60+

AAPA Statement on Passage of the “Big Beautiful Bill”

ALEXANDRIA, Va., July 3, 2025 /PRNewswire/ -- The American Academy of Physician Associates (AAPA) President and Chair of the Board, Todd Pickard, DMSc, PA-C,...

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight

The GPRC5D-directed therapies market is witnessing robust growth, driven by the high unmet need in relapsed/refractory multiple myeloma. Innovative modalities like CAR-T cells, bispecific...

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight

The GPRC5D-directed therapies market is witnessing robust growth, driven by the high unmet need in relapsed/refractory multiple myeloma. Innovative modalities like CAR-T cells, bispecific...

Westhaven Closes Non-Brokered Private Placement with Eric Sprott and Earthlabs, for Gross Proceeds of $3.16 Million

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

Techy Acquires NerdsToGo, Expanding Its Tech Franchise Powerhouse

Strategic acquisition unites two industry leaders to create a comprehensive tech support service network. FORT LAUDERDALE, Fla., July 3, 2025 /PRNewswire/ -- Techy, a global...

The Early Care & Education Consortium Applauds Congress for Enhancing Critical Child Care Tax Incentives

WASHINGTON, July 3, 2025 /PRNewswire/ -- The Early Care and Education Consortium (ECEC) applauds Congress for including $16 billion in child care tax incentives...

Bird Construction Inc. Announces Release Date and Conference Call for 2025 Second Quarter Financial Results

MISSISSAUGA, Ontario, July 03, 2025 (GLOBE NEWSWIRE) -- Bird Construction Inc. (TSX: BDT) announced today that it will release its 2025 second quarter financial results after market close on Wednesday, August 13, 2025. A conference call and live webcast to discuss the results will be held on Thursday, August 14, 2025 at 10:00 a.m. (ET).

BLUE & CO., LLC PROVIDES NOTICE OF DATA EVENT

CARMEL, Ind., July 3, 2025 /PRNewswire/ -- Blue & Co., LLC ("Blue") is a financial consultant for companies and is providing notice of an...

Bioma Probiotics Redefines Digestive Health in 2025 With Its Strongest Prebiotic, Probiotic, and Postbiotic Synergy Yet

Bioma’s transparency-driven formula highlights XOS prebiotics, targeted Bifidobacterium strains, and tributyrin postbiotics—meeting rising consumer demand for non-synthetic gut health support without promotional claims. 
Bioma’s transparency-driven formula highlights XOS prebiotics, targeted Bifidobacterium strains, and tributyrin postbiotics—meeting rising consumer demand for non-synthetic gut health support without promotional claims.

Ceres Global Ag Corp. Receives Final Order for Arrangement with Bartlett Grain Company

MINNEAPOLIS, MN, July 3, 2025 /CNW/ - Ceres Global Ag Corp. ("Ceres" or the "Corporation") (TSX: CRP) announced today that the Ontario Superior Court...

NAMI Statement on Final Passage of Bill Cutting Medicaid for Millions of Americans

Hundreds of billions of dollars in cuts to the Medicaid program will be devastating for mental health care ARLINGTON, Va., July 3, 2025 /PRNewswire/ --...

Scholastic Corporation Announces Date for Fourth Quarter and Fiscal 2025 Earnings Release and Conference Call

NEW YORK, July 3, 2025 /PRNewswire/ -- Scholastic Corporation (NASDAQ:SCHL) today announced the following schedule and conference call information for its fourth quarter and...

Brain Defender Enters 2025 Cognitive Wellness Spotlight as Demand for Transparent, Non-Stimulant Support Surges

As consumers turn to ingredient-based mental clarity tools, Brain Defender emphasizes formulation transparency and non-clinical support in the evolving cognitive wellness space. 
As consumers turn to ingredient-based mental clarity tools, Brain Defender emphasizes formulation transparency and non-clinical support in the evolving cognitive wellness space.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAccess

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers